# Take Rate, Immunogenicity and Safety of Elstree-BN Smallpox Vaccine in Healthy Vaccinia-Naive Subjects

> **NCT00189969** · PHASE1 · COMPLETED · sponsor: **Bavarian Nordic** · enrollment: 50 (—)

## Conditions studied

- Smallpox

## Interventions

- **BIOLOGICAL:** Elstree-BN

## Key facts

- **NCT ID:** NCT00189969
- **Lead sponsor:** Bavarian Nordic
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-09
- **Primary completion:** —
- **Final completion:** 2006-02
- **Target enrollment:** 50 (—)
- **Last updated:** 2006-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00189969

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00189969, "Take Rate, Immunogenicity and Safety of Elstree-BN Smallpox Vaccine in Healthy Vaccinia-Naive Subjects". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00189969. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*